-
LENZ Therapeutics Announces Everest Medicines Acquired Rights to Develop and Commercialize VIZZ® (LNZ100) in Greater China
The New Drug Application for LNZ100 in China was submitted September 2025 with approval anticipated in Q1 2027 June 07, 2026 19:30 ET | Source: LENZ Therapeutics, Inc. SAN DIEGO, June 07, 2026 (GLOBE NEWSWIRE) — LENZ Therapeutics, Inc. (Nasdaq: LENZ, “LENZ” or the “Company”), a pharmaceutical company focused on the commercialization of VIZZ® (aceclidine…
-
Forging India's Defence Future: Advancing Artillery Shell Manufacturing for Strategic Self-Reliance
India’s defence manufacturing sector is undergoing a pivotal transformation, and at the heart of this shift lies a capability that often goes unnoticed but is mission-critical – artillery shell manufacturing. These components, though rarely in the spotlight, form the very foundation of India’s ammunition strength. Their production is a matter of national security, industrial progress,…
-
SMPP Enters into Teaming Agreement with KNDS for KATANA®
SMPP, one of India’s leading defence and aerospace companies, has entered into a teaming agreement through its subsidiary SMPP Ammunition with KNDS for the KATANA® range of precision-guided artillery ammunition. The KATANA® is a 155mm precision-guided munition designed to deliver high accuracy and extended range, addressing critical operational needs of modern artillery systems. The agreement…
Latest News
About the Author
We increase the awareness of millions of users through our news networks. We are one of the most trusted news networks in the world.
